Blue Ridge Bankshares, Inc.
AMEX:BRBSBanks - Regional
+$0.05 today
- Market cap
- $355.16M
- Beta
- 0.56
- P/E (TTM)
- 24.7
- EPS (TTM)
- $0.14
- Dividend yield
- 25.34%
Volume 0.31M
Average 0.34M
BRBS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Blue Ridge Bankshares, Inc.AMEX: BRBS
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 14.0% from a year ago
Cash & equivalents stood at $146.61M at the end of Q1 FY2026, down 14.0% from a year earlier and up 26.4% from the prior quarter. Over 3 fiscal years it compounded at +14.5% a year.
Context
- Cash & equivalents amounted to 6.1% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -14.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 115.95M USD
- Year-over-year change
- -33.2%
- 4-year CAGR
- -2.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 115.95M | -33.2% |
| FY2024 | 2024-12-31 | 173.53M | +57.1% |
| FY2023 | 2023-12-31 | 110.49M | +43.0% |
| FY2022 | 2022-12-31 | 77.27M | -40.8% |
| FY2021 | 2021-12-31 | 130.55M | — |
Cash & Equivalents vs competitors
How BRBS compares with its peers on the latest reported figures
- BRBS's Mar 2026 cash & equivalents of $146.61M is the 3rd highest of the 11 companies compared; the peer median is $17.27M.
- Its year-over-year change of -14.0% is the 4th highest of 11, against a peer median of -63.0%.
- Cash & equivalents amounts to 6.1% of total assets for BRBS, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $208.9M | -28.5% | -13.3% | 6.2% | |
| Mar 2026 | $187.81M | -8.8% | +34.0% | 9.0% | |
| Mar 2026 | $146.61M | -14.0% | +14.5% | 6.1% | |
| Mar 2026 | $77.43M | +1.9% | +43.7% | 2.8% | |
| Mar 2026 | $36.96M | -58.5% | +30.9% | 0.8% | |
| Mar 2026 | $25.1M | -2.6% | -1.7% | 2.4% | |
| Mar 2026 | $9.44M | -92.4% | +16.1% | 0.4% | |
| Mar 2026 | $9.13M | -94.6% | +28.3% | 0.4% | |
| Mar 2026 | $8.5M | -67.6% | -47.5% | 0.5% | |
| Mar 2026 | $8.36M | -85.3% | +22.6% | 0.2% | |
| Mar 2026 | $7.98M | -93.5% | -6.0% | 0.4% | |
| Peer median (excluding BRBS) | $17.27M | -63.0% | +19.4% | 0.6% | |
Competitors are the stored peer set for BRBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 130.55M | 77.27M | 110.49M | 173.53M | 115.95M |
| Short-term Investments | 373.53M | 354.34M | 321.08M | 312.04M | 332.93M |
| Net Receivables | 9.57M | 11.57M | 14.97M | 12.54M | 10.79M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 513.65M | 443.18M | 446.54M | 498.11M | 459.66M |
| Property, Plant & Equipment (Net) | 32.94M | 30.06M | 31.09M | 29.36M | 28.19M |
| Goodwill | 26.83M | 26.83M | 0 | 0 | 0 |
| Intangible Assets | 24.06M | 35.57M | 32.5M | 4.25M | 2.64M |
| Long-term Investments | 1.95B | 2.5B | 2.48B | 2.14B | 0 |
| Tax Assets | 150K | 12.23M | 21.56M | 27.31M | 22.72M |
| Other Non-current Assets | 120.2M | 84.3M | 102.11M | 34.25M | 0 |
| Total Non-current Assets | 2.15B | 2.69B | 2.67B | 2.24B | 53.55M |
| Total Assets | 2.67B | 3.13B | 3.12B | 2.74B | 2.43B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.3B | 0 | 2.57B | 2.18B | 0 |
| Total Current Liabilities | 2.3B | 0 | 2.57B | 2.18B | 0 |
| Long-term Debt | 50.1M | 351.62M | 249.86M | 189.79M | 171.95M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 32.48M | 2.52B | 106.06M | 31.63M | (179.18M) |
| Total Non-current Liabilities | 90.23M | 2.88B | 365.53M | 230.03M | 0 |
| Total Liabilities | 2.39B | 2.88B | 2.93B | 2.41B | 2.11B |
| Common Stock | 194.31M | 195.96M | 197.64M | 322.79M | 331.92M |
| Retained Earnings | 85.98M | 97.68M | 33.16M | 17.77M | (659K) |
| Accumulated OCI | (3.63M) | (45.1M) | (45.06M) | (42.46M) | (31.12M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 228K | 0 | 0 | 0 | 0 |
| Total Equity | 277.14M | 248.79M | 185.99M | 327.79M | 323.69M |
| Total Debt | 57.75M | 359.48M | 259.47M | 198.4M | 179.18M |
| Net Debt | (72.8M) | 282.21M | 148.98M | 24.87M | 63.23M |
Blue Ridge Bankshares, Inc.
AMEX:BRBS
Intrinsic Alpha fair value
Locked
Current Price
$3.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.